BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 4898857)

  • 21. [Therapy of acute leukemias in children. 2].
    Jacquillat C; Weil M; Schaison G; Delobel J; Bussel A; Brunel-Kotschi R; Gemon MF; Loisel JP
    Med Klin; 1972 Aug; 67(32):1040-5. PubMed ID: 4506878
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical trials of asparaginase in chemotherapy-resistant acute leukemias.
    Goudemand M; Bauters F
    Recent Results Cancer Res; 1970; 33():316-22. PubMed ID: 5292721
    [No Abstract]   [Full Text] [Related]  

  • 23. Depression of functional and antigenic plasma antithrombin III (AT-III) due to therapy with L-asparaginase.
    Liebman HA; Wada JK; Patch MJ; McGehee W
    Cancer; 1982 Aug; 50(3):451-6. PubMed ID: 7046902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-asparaginase in the treatment of neoplastic diseases in children.
    Jaffe N; Traggis D; Das L; Moloney WC; Hann HW; Kim BS; Nair R
    Cancer Res; 1971 Jul; 31(7):942-9. PubMed ID: 4327086
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapy of leukemia in USA. 2. L asparaginase in leukemia].
    Böttiger LE
    Lakartidningen; 1969 Jan; 66(5):455-60. PubMed ID: 5254602
    [No Abstract]   [Full Text] [Related]  

  • 26. L-asparaginase--clinical experience in leukaemia, lymphoma and carcinoma.
    Biggs JC; Chesterman CN; Holliday J
    Aust N Z J Med; 1971 Feb; 1(1):1-7. PubMed ID: 4934741
    [No Abstract]   [Full Text] [Related]  

  • 27. [Asparaginase, 1969].
    Boiron M; Levy D
    Pathol Biol (Paris); 1969 Dec; 17(23):1129-32. PubMed ID: 4908018
    [No Abstract]   [Full Text] [Related]  

  • 28. [First results of the treatment of acute leukemia with L-asparaginase].
    Marmont A; Damasio E; Bordo D; Fazio F; Gori E; Rossi F
    Haematologica; 1970; 55(9):593-6. PubMed ID: 4996527
    [No Abstract]   [Full Text] [Related]  

  • 29. [L-asparaginase in the treatment of lymphoblastic leukemia in children].
    Bohlmann HG; Gallmeier WM; Göbel FJ; Stier HW
    Z Kinderheilkd; 1969; 107(2):107-14. PubMed ID: 5262681
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of acute leukemia with L-asparaginase--preliminary results on 84 cases.
    Jacquillat C; Weil M; Bussel A; Loisel JP; Rouesse T; Larrieu MJ; Boiron M; Dreyfus B; Bernard J
    Recent Results Cancer Res; 1970; 33():263-78. PubMed ID: 5292720
    [No Abstract]   [Full Text] [Related]  

  • 31. [Adverse reactions associated with the use of L-asparaginase during therapy of patients with nB non-Hodgkin's lymphoma. Report of the Polish Paediatric LeuKaemia/Lymphoma Study Group].
    Wróbel G; Dobaczewski G; Kazanowska B; Bogusławska-Jaworska J; Balwierz W; Balcerska A; Bubała H; Dluzniewska A; Kołecki P; Kowalczyk J; Kurylak A; Maciejka-Kapuscinska L; Matysiak M; Rokicka-Milewska R; Sońta-Jakimczyk D; Sopyło B; Stefaniak MJ; Stefańska K; Stańczak E; Wysocki M
    Med Wieku Rozwoj; 2000; 4(1 Suppl 2):67-72. PubMed ID: 12021464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-asparaginase (NSC-109229) plus azaserine (NSC-742) in acute lymphatic leukemia.
    Leventhal BG; Skeel RT; Yankee RA; Henderson ES
    Cancer Chemother Rep; 1970 Feb; 54(1):47-51. PubMed ID: 4945997
    [No Abstract]   [Full Text] [Related]  

  • 33. L-asparaginase therapy and its complications in acute lymphoid leukaemia and generalized lymphosarcoma.
    Schuler D; Koós R; Révész T; Virág I; Gálfi I
    Haematologia (Budap); 1976; 10(2):205-11. PubMed ID: 1071740
    [No Abstract]   [Full Text] [Related]  

  • 34. L-Asparaginase: human toxicology and single agent activity in nonleukemic neoplasms.
    Haskell CM
    Cancer Treat Rep; 1981; 65 Suppl 4():57-9. PubMed ID: 7049381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Apropos of certain toxic effects of L-asparaginase in human therapy].
    Oberling F; Cazenave JP; Lang JM; Kurtz D; Mayer G; Waitz R
    Sem Hop; 1971 May; 47(22):1421-5. PubMed ID: 4326093
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful remission induction in children with acute lymphocytic leukemia at high risk for treatment failure.
    Aur RJ; Simone JV; Pratt CB
    Cancer; 1971 Jun; 27(6):1332-6. PubMed ID: 5282619
    [No Abstract]   [Full Text] [Related]  

  • 37. Asparaginase in acute leukaemia.
    Colebatch JH; Matthews RN; Gordon PM; Tan CL; Santamaria JN; Lay HN
    Med J Aust; 1970 Feb; 1(6):282. PubMed ID: 5266297
    [No Abstract]   [Full Text] [Related]  

  • 38. [Results of a cooperative clinical study of Soviet L-asparaginase from E. coli].
    Kondrat'eva NA; Lorie IuI; Kruglova GV; Vorob'ev AI; Brilliant MD
    Probl Gematol Pereliv Krovi; 1980 Jul; 25(7):3-9. PubMed ID: 6995975
    [No Abstract]   [Full Text] [Related]  

  • 39. [L-asparaginase in the treatment of solid tumors and leukemia].
    Heim RR; Freiberg J; Gehrmann G
    Dtsch Med Wochenschr; 1970 May; 95(18):989-93. PubMed ID: 5269095
    [No Abstract]   [Full Text] [Related]  

  • 40. A summary of the clinical status of asparaginase.
    Burchenal JH
    Recent Results Cancer Res; 1970; 33():350-4. PubMed ID: 5292724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.